- De-Risking a Rare Disease Launch Starts with PrecisionWhy traditional models fall short in rare disease commercialization—and what works instead.Fierce Biotech · 1mo ago↗ source
- Biopharma’s LGBTQ+ leaders; Novo Nordisk hacked?; and moreWelcome back to another edition of Endpoints Weekly! The summer solstice arrives this weekend — the northern hemisphere will reach its maximum tilt toward the sun at 4:24 a.m. Eastern time on Sunda…Endpoints · 1mo ago↗ source
- Endpoints News History: 10 Years, Bootstrap to FTTen years of Endpoints News: no investors, a 50/50 split, profitable from day one. Co-founders Arsalan Arif and John Carroll on how the partnership held.Endpoints · 1mo ago↗ source